Wegovy® Shed Membership

$99/month (medication not included)

Wegovy® (semaglutide) is an FDA-approved medication for weight loss.* When paired with healthy habits, it's a valuable tool for adults with obesity or excess weight looking to lose weight and improve their overall health.

For just $99/month, our program includes all the support you need on your weight-loss journey, from provider visits and text-based Health Coaching** to educational resources and a community to root for you. Set yourself up for success and unveil the real you with Shed’s Wegovy® Membership. Medication not included.

Wegovy® Shed Membership
$99/month (medication not included)

Wegovy® (semaglutide) is an FDA-approved medication for weight loss.* When paired with healthy habits, it's a valuable tool for adults with obesity or excess weight looking to lose weight and improve their overall health.

For just $99/month, our program includes all the support you need on your weight-loss journey, from provider visits and text-based Health Coaching** to educational resources and a community to root for you. Set yourself up for success and unveil the real you with Shed’s Wegovy® Membership. Medication not included.

Clinically proven results†
Helps support appetite control
Supports healthy metabolic function

What included in the
Shed Membership?

What's included in the
Shed Membership?

Unlimited provider visits
Shed Community access with resources, educational courses, nutrition plans, and continuous support
Support from our Member Success and medical teams every step of the way
Complimentary text-based Health Coaching** for ongoing guidance
Dedicated support on prescription orders—no more insurance hassles!
Medication not included.

What's included in the
Shed Membership?

What included in the
Shed Membership?

Unlimited provider visits
Shed Community access with resources, educational courses, nutrition plans, and continuous support
Support from our Member Success and medical teams every step of the way
Complimentary text-based Health Coaching** for ongoing guidance
Dedicated support on prescription orders—no more insurance hassles!
Medication not included.

How Wegovy® supports weight management

Slows digestion, which can help you feel full for longer
Helps reduce cravings
Helps regulate appetite
Supports healthy metabolic function
FDA approved
Clinically proven
Easy to use

Shed journey

3-minute signup, 100% online
Receive a personalized plan.
Fill out a quick online form with your goals and health history. We’ll assess your eligibility and craft a personalized treatment plan just for you.
Take the leap.
Your medication will be delivered to your doorstep—no pharmacy lines, no hassle.
Experience lasting results.
Stay in touch with your Member Success Team, who are dedicated to helping you reach your desired results.

A clinically backed solution

Wegovy® offers an option for patients who’ve struggled with weight loss for years. It works with your body’s natural appetite signals, potentially making it easier to eat less without feeling deprived.
Dr. Asad Niazi

Doctor of Medicine (MD)
Internal Medicine Physician

Wegovy® offers an option for patients who’ve struggled with weight loss for years. It works with your body’s natural appetite signals, potentially making it easier to eat less without feeling deprived.

Looking for weight-loss solutions?

While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.

Explore all our GLP-1 Solutions →
100% online visit + checkout
1:1 expert care
Clinically-backed
Simple, achievable results

You're a few clicks away from Wegovy®

Wegovy®
$99/month
Injected weekly
1-month supply
FDA approved for weight loss

Questions about Wegovy® Shed Membership? We've got answers.

What is Wegovy® and how does it work?

Wegovy® is a once-weekly GLP-1 receptor agonist designed to mimic a natural hormone that helps regulate appetite and food intake. It signals the brain to reduce hunger and slow down digestion, which helps patients feel fuller for longer.

What kind of results can I expect on Wegovy®?

Most patients begin seeing meaningful weight loss within the first few weeks, especially when paired with lifestyle changes. Clinical trials showed average weight loss of up to 15% of total body weight over 68 weeks.

What’s the difference between Ozempic® and Wegovy®?

 Both contain semaglutide, but Ozempic® is FDA-approved for Type 2 diabetes management, while Wegovy® is specifically approved for weight loss. That said, many providers prescribe Ozempic® off-label for weight management when appropriate.

How do I take Wegovy®?

It’s a simple subcutaneous injection taken once a week. It can be administered in the stomach, thigh, or upper arm—whatever’s most comfortable for you.

Are there any side effects of Wegovy®?

The most common side effects are gastrointestinal—things like nausea, constipation, or mild bloating. These are usually temporary and improve as your body adjusts.

Ready to get started?

During your free consultation, a licensed provider will assess your health needs to determine if Wegovy® is the right fit for your weight-loss journey.

*Wegovy® (semaglutide) is FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. Individual results may vary. The most common side effects are gastrointestinal, including nausea, constipation, or mild bloating, which typically improve as your body adjusts. Wegovy® is a prescription medication and is prescribed only after consultation with a licensed healthcare provider to determine appropriateness.

**Text-based coaching is powered by AI and monitored by a licensed coach. Responses may be automated, but your coach reviews interactions to ensure quality and support.

†Based on a 68-week study of adults with obesity or overweight who also had weight-related medical problems, including high blood pressure or high cholesterol. Learn more about the study here.